nx-2127,nx-5948
nurix therapeutics
['nx-2127', 'nx-5948', 'cml', 'nurix']
we will have 4 presentations at #17icml, highlighting clinical and preclinical data for our btk degraders, nx-5948 and nx-2127, which are being developed for the treatment of relapsed or refractory b-cell malignancies. check out the posters here: 
Targeted #proteindegradation is only the beginning. Blazing a new path in medicine. $NRIX